BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 17629386)

  • 21. Presence of ochratoxin A in Tunisian blood nephropathy patients. Exposure level to OTA.
    Zaied C; Bouaziz C; Azizi I; Bensassi F; Chour A; Bacha H; Abid S
    Exp Toxicol Pathol; 2011 Nov; 63(7-8):613-8. PubMed ID: 20708395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ochratoxin A genotoxicity, relation to renal tumors].
    Maaroufi K; Pfohl-Leszkowicz A; Achour A; el May M; Grosse Y; Hammami M; Ellouz F; Creppy EE; Bacha H
    Arch Inst Pasteur Tunis; 1994; 71(1-2):21-31. PubMed ID: 7661650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ochratoxin A: lack of formation of covalent DNA adducts.
    Mally A; Zepnik H; Wanek P; Eder E; Dingley K; Ihmels H; Völkel W; Dekant W
    Chem Res Toxicol; 2004 Feb; 17(2):234-42. PubMed ID: 14967011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Hsp70 in kidney cells exposed to ochratoxin A.
    Barisić K; Petrik J; Rumora L; Cepelak I; Grubisić TZ
    Arch Toxicol; 2002 May; 76(4):218-26. PubMed ID: 12029385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ochratoxin A and beta2-microglobulinuria in healthy individuals and in chronic interstitial nephropathy patients in the centre of Tunisia: a hot spot of Ochratoxin A exposure.
    Hassen W; Abid S; Achour A; Creppy E; Bacha H
    Toxicology; 2004 Jul; 199(2-3):185-93. PubMed ID: 15147792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells.
    Kamp HG; Eisenbrand G; Schlatter J; Würth K; Janzowski C
    Toxicology; 2005 Jan; 206(3):413-25. PubMed ID: 15588931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The involvement of mycotoxins in the development of endemic nephropathy.
    Peraica M; Domijan AM; Miletić-Medved M; Fuchs R
    Wien Klin Wochenschr; 2008; 120(13-14):402-7. PubMed ID: 18726664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms.
    Marin-Kuan M; Cavin C; Delatour T; Schilter B
    Toxicon; 2008 Aug; 52(2):195-202. PubMed ID: 18649906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycotoxins and the kidney: modes of action for renal tumor formation by ochratoxin A in rodents.
    Mally A; Dekant W
    Mol Nutr Food Res; 2009 Apr; 53(4):467-78. PubMed ID: 19072886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotoxic effects of Ochratoxin A in Wistar rats after oral administration.
    Alvarez L; Gil AG; Ezpeleta O; García-Jalón JA; López de Cerain A
    Food Chem Toxicol; 2004 May; 42(5):825-34. PubMed ID: 15046829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk estimation for ochratoxin A in European countries.
    Frank HK
    IARC Sci Publ; 1991; (115):321-5. PubMed ID: 1820348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heat shock proteins (Hsp 70) response is not systematic to cell stress: case of the mycotoxin ochratoxin A.
    Hassen W; Ayed-Boussema I; Bouslimi A; Bacha H
    Toxicology; 2007 Dec; 242(1-3):63-70. PubMed ID: 17981385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ochratoxin A and other mycotoxins in cereals from an area of Balkan endemic nephropathy and urinary tract tumours in Bulgaria.
    Petkova-Bocharova T; Castegnaro M; Michelon J; Maru V
    IARC Sci Publ; 1991; (115):83-7. PubMed ID: 1820357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ochratoxin A and β2-microglobulin in BEN patients and controls.
    Yordanova P; Wilfried K; Tsolova S; Dimitrov P
    Toxins (Basel); 2010 Apr; 2(4):780-92. PubMed ID: 22069610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro cytogenetic results supporting a DNA nonreactive mechanism for ochratoxin A, potentially relevant for its carcinogenicity.
    Mosesso P; Cinelli S; Piñero J; Bellacima R; Pepe G
    Chem Res Toxicol; 2008 Jun; 21(6):1235-43. PubMed ID: 18500787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA adduct formation by ochratoxin A: review of the available evidence.
    Mally A; Dekant W
    Food Addit Contam; 2005; 22 Suppl 1():65-74. PubMed ID: 16332624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are mycotoxins risk factors for endemic nephropathy and associated urothelial cancers?
    Castegnaro M; Chernozemsky IN; Hietanen E; Bartsch H
    Arch Geschwulstforsch; 1990; 60(4):295-303. PubMed ID: 2202269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor.
    Pfohl-Leszkowicz A; Tozlovanu M; Manderville R; Peraica M; Castegnaro M; Stefanovic V
    Mol Nutr Food Res; 2007 Sep; 51(9):1131-46. PubMed ID: 17729220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity.
    Adler M; Müller K; Rached E; Dekant W; Mally A
    Carcinogenesis; 2009 Apr; 30(4):711-9. PubMed ID: 19237604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ochratoxin A, ubiquitous mycotoxin contaminating human food].
    Pfohl-Leszkowicz A
    C R Seances Soc Biol Fil; 1994; 188(4):335-53. PubMed ID: 7736257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.